SODIUM PHENYLBUTYRATE
Background and Date of Approval
Sodium phenylbutyrate has been in clinical use since the early 1990s, developed as part of a significant advance in managing urea cycle disorders (UCDs), rare genetic conditions where the body cannot eliminate ammonia effectively. This toxic metabolite accumulates in the blood. The medication received regulatory approval, including from the U.S. FDA, in 1996 and is now established as a standard therapeutic option for patients with UCDs. Due to its role in preventing life-threatening ammonia accumulation, it is recognised as an essential medication for long-term metabolic management in these patients.
Uses
Sodium Phenylbutyrate.NMP is used to: Manage urea cycle disorders (UCDs) in children and adults. Help control high blood ammonia levels (hyperammonemia). Serve as a long-term maintenance therapy to prevent ammonia spikes. Support patients who cannot adequately control ammonia through diet alone. Reduce the risk of confusion, vomiting, lethargy, seizures, or coma caused by ammonia accumulation. It is used alongside a low-protein diet, sometimes with supplements such as amino acids or specific vitamins.
Side Effects
Even though Ammobula Powder is generally safe when used as prescribed, some individuals may experience side effects. Common side effects include: Serious Side Effects: Severe allergic reactions (rash, itching, swelling) Liver dysfunction Muscle weakness Dehydration Common Side Effects: Nausea Vomiting Diarrhea Loss of appetite Abdominal discomfort If you experience any of these side effects or notice unusual symptoms, it is crucial to seek medical attention immediately.
References
Brundin et al. (2008). Phenylbutyrate in the management of urea cycle disorders. Journal of Clinical Chemistry. [Accessed 14th July 2023] https://academic.oup.com/CustomError?statusCode=404&404%3bhttp%3a%2f%2facademic.oup.com%3a80%2fjclinchem%2farticle%2f46%2f10%2f1574%2f761573%3flogin=false&login=false National Institute of Health (NIH), Urea Cycle Disorders (UCDs). [Accessed 14th July 2023] https://www.ninds.nih.gov/health-information/disorders/urea-cycle-disorders
Frequently Asked Questions
What is the primary use of Ammobula Powder?
Ammobula Powder is primarily used to treat urea cycle disorders by lowering elevated blood ammonia levels, thereby preventing toxicity.
How should Ammobula Powder be taken?
Ammobula Powder should be taken orally, as directed by your doctor. It can be mixed with food or liquids to make consumption easier.
Are there any specific precautions before using Ammobula Powder?
Before using Ammobula Powder, inform your doctor if you have liver disease, are pregnant or breastfeeding, or are taking other medications that may interact with Sodium Phenylbutyrate.
Can Ammobula Powder be used in children?
Ammobula Powder can be used in children, but the dosage must be carefully prescribed by a healthcare provider based on the child's condition and medical history.
What should I do if I miss a dose of Ammobula Powder?
If you miss a dose, take it as soon as you remember. However, if it is close to the time of your next dose, skip the missed dose. Do not double the dose to make up for a missed one.